Institutional equity research analysts covering Lifeway Foods, Inc. (NASDAQ: LWAY) maintain a consensus rating leaning toward a Buy, supported by consistent double-digit net sales growth and expanding retail distribution for its probiotic kefir products, tempered by recent quarterly margin pressures.